Cohen A J, Arnaudov D, Zabeeda D, Schultheis L, Lashinger J, Schachner A
Department of Cardiovascular Surgery, The Edith Wolfson Medical Center, Holon, Israel.
Eur J Cardiothorac Surg. 1998 Jul;14(1):64-9. doi: 10.1016/s1010-7940(98)00135-3.
A new device, using whole body bioresistance measurements and a new equation for calculating stroke volume has been developed. Using this equation, an attempt was made to correlate whole body bioresistance cardiac output with thermodilution cardiac output in patients undergoing coronary artery bypass grafting.
Thirty-one adults undergoing elective coronary artery bypass grafting were studied prospectively. Simultaneous paired cardiac output measurements by whole body bioresistance and thermodilution were made at five time points during coronary artery bypass grafting: in anesthetized patients before incision (T1), after sternotomy (T2), after opening the pericardium (T3), ten min post bypass (T4), and in the intensive care unit (T5). The patients had a mean of three thermodilution cardiac outputs compared with a mean of three bioimpedance measurements at each time point. The bias and precision between the methods were calculated.
There was good correlation between bioresistance cardiac output (nCO) and thermodilution cardiac output (ThCO) measurements in both groups for all recorded times. The patients' mean ThCO and nCO, as well as bias and precision between methods were calculated. Mean ThCO ranged between 4.14 and 5.06 l/min; mean nCO ranged between 4.12 and 4.97 l/ min. Bias calculations ranged between -0.072 and 0.104 l/min. Precision (2 SD) calculations ranged between 0.873 and 1.228 l/min for 95% confidence intervals. Pearson's correlation ranged from 0.919 to 0.938.
Cardiac output measured with the new device correlates well with the thermodilution measurements of cardiac output during and immediately following coronary artery bypass grafting. The overall agreement between the two methods was good. The new device is an accurate non-invasive method of measuring cardiac output during coronary artery bypass grafting.
已研发出一种新设备,其采用全身生物电阻抗测量技术及一种新的每搏输出量计算方程。利用该方程,尝试在接受冠状动脉旁路移植术的患者中,将全身生物电阻抗心输出量与热稀释法心输出量进行关联。
对31例接受择期冠状动脉旁路移植术的成年人进行前瞻性研究。在冠状动脉旁路移植术的五个时间点,同时采用全身生物电阻抗法和热稀释法配对测量心输出量:麻醉后切开前(T1)、胸骨切开后(T2)、打开心包后(T3)、旁路术后10分钟(T4)以及在重症监护病房(T5)。每个时间点,患者平均进行三次热稀释法心输出量测量,与之相比,平均进行三次生物阻抗测量。计算两种方法之间的偏差和精密度。
在所有记录时间内,两组中生物电阻抗心输出量(nCO)与热稀释法心输出量(ThCO)测量值之间均具有良好的相关性。计算了患者的平均ThCO和nCO,以及两种方法之间的偏差和精密度。平均ThCO范围为4.14至5.06升/分钟;平均nCO范围为4.12至4.97升/分钟。偏差计算范围为-0.072至0.104升/分钟。95%置信区间的精密度(2SD)计算范围为0.873至1.228升/分钟。Pearson相关性范围为0.919至0.938。
在冠状动脉旁路移植术期间及术后即刻,使用新设备测量的心输出量与热稀释法测量的心输出量具有良好的相关性。两种方法之间的总体一致性良好。新设备是一种在冠状动脉旁路移植术期间测量心输出量的准确无创方法。